High throughput screening

#Drug discovery #High throughput screening #Multi-omics #Omics

Understanding the value of multi-omics

DDW’s Megan Thomas discusses the opportunity in the multi-omics sector by speaking with leading players and looking at the ways in which it can help us tackle disease. Importance of the multi-omics sector Multi-omics describes the crossover application of many high‐throughput screening technologies. These include genomics, transcriptomics, proteomics, metabolomics, epigenomics, glycomics,… Read More

#Exclusive Content

#Artificial intelligence (AI) #CRISPR screening #High throughput screening #Screening

Advances in drug discovery screening

DDW Editor Reece Armstrong takes a look at some recent advances in screening that are helping scientists in the drug discovery process.  Screening is an essential part of the drug discovery process in which researchers analyse large libraries of compounds in order to discover promising molecule that demonstrate a therapeutic… Read More

#Exclusive Content

#Cancer research #Career #Chemical biology #Curve Therapeutics #Drug discovery #High throughput screening #Interview #Meet the Researcher #Next generation sequencing #Target identi

Meet the researcher: Ali Tavassoli

DDW’s Megan Thomas talks to Ali Tavassoli, Chief Scientific Officer of Curve Therapeutics and Professor of Chemical Biology at the University of Southampton, UK.  MT: Where do you work, and can you tell us what you’re working on at the moment?  AT: We spun Curve out of my academic group five… Read More

#Cancer Research #Exclusive Content

384-well microplate
#BMG Labtech #High throughput screening #Microplate readers

High-throughput screening applications on microplate readers

This article is sponsored by BMG Labtech. High-throughput screening (HTS) is predominantly used in drug discovery and relevant to the pharmaceutical industry as well as academic core facilities. With HTS, researchers can quickly test large libraries of chemical, biochemical, or pharmacological samples for drug candidates. To maximise efficiency, screening facilities… Read More

#Exclusive Content

#Evotec #Genomics #High throughput screening #Metabolomics #Multi-omics #Proteomics #Transcriptomics

PanOmics: Advancing drug discovery

This article is sponsored by Evotec. To enable Evotec’s precision medicine approach, we have been building technology platforms that allow PanOmics or multi-omics data generation at an industrialised scale. The technologies cover the whole range of biomolecules from genes to protein to metabolites. While we are using… Read More

#News

Scientist Loads Samples Into Mercury
#AI / data analytics / healthtech / informatics #Arrayjet #Assay development & optimisation #Chemspace #Collaboration #High throughput screening

Arrayjet announces collaboration with Chemspace

Arrayjet and Chemspace have agreed a partnership to augment and streamline Chemspace’s small molecule microarray (SMM) service offering. Chemspace’s compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract array manufacturing. SMMs enable high-throughput screening of compound… Read More

#News

Neurons
#AAV #Genetics / genomics #High throughput screening #Neuroscience #Sania Therapeutics #University College London

Start-up will focus on medicines for neural circuit dysfunction

Sania Therapeutics, a new company focused on developing genetic medicines for neural circuit dysfunction, has launched at the American Society of Gene & Cell Therapy (ASGCT) conference. The company’s approach combines adeno-associated viruses (AAV) in human neural circuits with tuneable conditionally-activated ion channels. This corrects dysfunctional neural excitation. Sania’s technology… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Automation / robotics #Europe #Events #High throughput screening #Lab automation #SLAS Europe

What to expect from SLAS Europe 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. DDW’s Multimedia Editor Megan Thomas explores what to expect from the event. Scientific tracks SLAS Europe 2023 will feature four tracks focused on life sciences and their global impact:… Read More

#Exclusive Content

#Antibodies #Drug discovery #Events #High throughput screening #Protein inhibitor

Symposium: Unlock high-throughput biology

The Carterra 2023 Symposia Series ‘Unlocking High-Throughput Biology and Drug Discovery’ is now open for registrations. Join industry-leading scientists from GSK, Oxford University, LifeArc, Alloy Therapeutics, Sanofi, and Carterra on April 19, 2023 in Cambridge, UK for this one-day, science-filled experience. Learn about the current advancements… Read More

#News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

New listicle: Five tips on scaling up IVT for mRNA production

The success of messenger RNA or mRNA vaccines in the fight against the global SARS-CoV-2 crisis brings a new era of vaccine development. In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. By partnering… Read More

#Editor's Choice #News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

Listicle: Five tips on scaling up IVT for mRNA production

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More

#Listicles #Videos

DNA sequencing
#Collaboration #Genetics / genomics #Genome sequencing #High throughput screening #Lab automation #Library screening #Oxford Nanopore Technologies #Partnership #The Tecan Group

Alliance hopes to automate nanopore library preparation

The Tecan Group and Oxford Nanopore Technologies will collaborate to drive easier high throughput nanopore library preparation in an automated, hands-free fashion.   The aim of the partnership is a fully automated workflow for Oxford Nanopore’s Ligation Sequencing Kit XL V14 protocol (LSK114) with Tecan’s DreamPrep NGS solutions.  The LSK114 protocol… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Cloud computing #High throughput screening #Lab automation #Machine learning #SLAS2023

How ML and automation are changing the future of protein therapeutics

Kristen Hopson, Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yue Liu, Associate Director, HTS at Generate Biomedicines, reflect on the impact of artificial intelligence (AI), machine learning (ML), cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research. Proteins are the basic… Read More

#Exclusive Content

#Biomedicine #Cloud computing #High throughput screening #Lab automation #Life sciences #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Podcast: ML and lab automation are changing protein therapeutics

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode four, How machine learning and lab automation are changing the… Read More

#News

Laboratory technology
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Charles River #Collaboration #DNA technology #High throughput screening #Medicinal chemistry #Partnership #Pioneering Medicines

Partners enter multi-programme drug discovery agreement

Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica.  Through the agreement, Pioneering Medicines will apply Logica across a portfolio of targets with the aim of creating optimised small molecules… Read More

#News

Research lab
#Cancer research #circular RNAs #Collaboration #Esperovax #Ginkgo Bioworks #High throughput screening #Oncology #Partnership #RNA

Alliance to develop circular RNA-based therapeutics

Esperovax and Ginkgo Bioworks have agreed a partnership to develop circular RNAs (circRNAs) for a variety of therapeutic applications.   Initially, the companies will work to develop circRNAs harbouring payloads to specifically target colorectal cancer by inducing cell death only in cancerous cells.  CircRNAs represent an… Read More

#Cancer Research #News